NCT03236298View on ClinicalTrials.gov

Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: Comparing 125 mL/h Versus 250 mL/h Bolus Delivery Flow

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

January 22, 2020

Study Completion Date

January 23, 2020

Conditions
Labor Pain
Interventions
DEVICE

CADD-Solis Ambulatory Infusion System

The CADD-Solis pump will administer programmed intermittent boluses of 0.0625% Bupivacaine plus fentanyl 2mcg/ml.

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT03236298 - Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: Comparing 125 mL/h Versus 250 mL/h Bolus Delivery Flow | Biotech Hunter | Biotech Hunter